"We operate 24 hours a day, providing specialised care to adult patients with a serious illness or injury."

During the past decade, Royal Brisbane and Women's Hospital conducted 220 clinical trials. In the 10-year time frame, 220 clinical trials started and 127 clinical trials were completed, i.e. on average, 57.7% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 73 clinical trials were completed. i.e. 76.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Brisbane and Women's Hospital" #1 sponsor was "Children's Oncology Group" with 30 trials, followed by "The University of Queensland" with 21 trials sponsored, "Trans Tasman Radiation Oncology Group" with 17 trials sponsored, "Gilead Sciences" with 16 trials sponsored and "Hoffmann-La Roche" with 16 trials sponsored. Other sponsors include 333 different institutions and companies that sponsored additional 166 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Brisbane and Women's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "National Health and Medical Research Council, Australia" with 22 trials as a collaborator, "Royal Brisbane and Women's Hospital" with 17 trials as a collaborator, "The University of Queensland" with 12 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 390 different institutions and companies that were collaborators in the rest 265 trials.

According to Clinical.Site data, the most researched conditions in "Royal Brisbane and Women's Hospital" are "Amyotrophic Lateral Sclerosis" (13 trials), "Breast Cancer" (11 trials), "Ovarian Cancer" (11 trials), "Ulcerative Colitis" (9 trials) and "Multiple Myeloma" (8 trials). Many other conditions were trialed in "Royal Brisbane and Women's Hospital" in a lesser frequency.

Most popular intervention types in "Royal Brisbane and Women's Hospital" are "Drug" (319 trials), "Other" (84 trials), "Biological" (44 trials), "Radiation" (43 trials) and "Procedure" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (77 trials), "Cyclophosphamide" (20 trials), "Laboratory Biomarker Analysis" (20 trials), "Doxorubicin Hydrochloride" (14 trials) and "Dexamethasone" (13 trials). Other intervention names were less common.

The vast majority of trials in "Royal Brisbane and Women's Hospital" are 376 trials for "All" genders, 39 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Brisbane and Women's Hospital". 4 are not yet recruiting, 70 are recruiting, 75 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 218 completed trials in Royal Brisbane and Women's Hospital, undefined suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Brisbane and Women's Hospital, 38 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 203 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 42 trials that are defined as “Not Applicable".